INBS (Intelligent Bio Solutions) Short-Term Debt: $0.00 Mil (As of Mar. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

INBS Intelligent Bio Solutions Inc INBS
50 GF Score
Price $1.81
GF Value $2.64
Valuation Possible Value Trap
! 3 Warning Signs
View Full Analysis

What is Intelligent Bio Solutions Short-Term Debt?

Intelligent Bio Solutions INBS -0.55% 50 Short-Term Debt is $0.00 Mil as of Mar. 2026. GuruFocus rates INBS with a GF Score™ of 50/100 and a GF Value™ of $2.64 (Possible Value Trap). The stock has 3 warning signs investors should review.

Intelligent Bio Solutions's Short-Term Debt for the quarter that ended in Mar. 2026 was $0.00 Mil.

Intelligent Bio Solutions's quarterly Short-Term Debt declined from Sep. 2025 ($0.14 Mil) to Dec. 2025 ($0.01 Mil) and declined from Dec. 2025 ($0.01 Mil) to Mar. 2026 ($0.00 Mil).

Intelligent Bio Solutions's annual Short-Term Debt increased from Jun. 2023 ($0.35 Mil) to Jun. 2024 ($0.52 Mil) but then declined from Jun. 2024 ($0.52 Mil) to Jun. 2025 ($0.20 Mil).

Intelligent Bio Solutions Short-Term Debt Explanation

Short-Term Debt represents the total amount of Long-Term Debt such as bank loans and commercial paper, which is due within one year.

Intelligent Bio Solutions Short-Term Debt Related Terms

Intelligent Bio Solutions Short-Term Debt Historical Data

* Premium members only.

The historical data trend for Intelligent Bio Solutions's Short-Term Debt can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Intelligent Bio Solutions Short-Term Debt Chart

Intelligent Bio Solutions Annual Data
Trend Jun17 Jun18 Jun19 Jun20 Jun21 Jun22 Jun23 Jun24 Jun25
Short-Term Debt
Get a 7-Day Free Trial Premium Member Only 0.00 0.00 0.35 0.52 0.20

Intelligent Bio Solutions Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Short-Term Debt Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.36 0.20 0.14 0.01 0.00
INBS
50GF Score
Intelligent Bio Solutions Inc INBS
Short-Term Debt is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis
Frequently Asked Questions Learn more about Short-Term Debt →
What does a Short-Term Debt of $0.00 Mil mean?
Intelligent Bio Solutions (INBS) has a Short-Term Debt of $0.00 Mil as of Mar. 2026.
Is Intelligent Bio Solutions' Short-Term Debt too high?
Intelligent Bio Solutions' current Short-Term Debt is $0.00 Mil. Overall, Intelligent Bio Solutions has a GF Score™ of 50/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does Intelligent Bio Solutions' Short-Term Debt compare to ITOC and WOK?
Intelligent Bio Solutions' Short-Term Debt of $0.00 Mil can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Short-Term Debt for a Medical Devices & Instruments company?
A good Short-Term Debt depends on the Medical Devices & Instruments industry context. However, Short-Term Debt should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Short-Term Debt mean?
A high Short-Term Debt can signal that a stock is expensive relative to its fundamentals. Intelligent Bio Solutions's current Short-Term Debt is $0.00 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Intelligent Bio Solutions stock overvalued right now?
Based on GuruFocus' analysis, Intelligent Bio Solutions (INBS) is currently considered Possible Value Trap. The stock's GF Value™ is $2.64, compared to a current price of $1.81 — trading 31.4% below its estimated fair value. The current Short-Term Debt is $0.00 Mil. Intelligent Bio Solutions' overall GF Score™ is 50/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Short-Term Debt calculated?
Short-Term Debt is calculated from a company's financial statements. For Intelligent Bio Solutions (INBS), the current Short-Term Debt is $0.00 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Intelligent Bio Solutions (INBS) Overvalued in 2026?

Based on GuruFocus' analysis, Intelligent Bio Solutions stock appears to be undervalued. The current stock price of $1.81 is trading 31.4% below its estimated GF Value™ of $2.64. GuruFocus considers Intelligent Bio Solutions to be Possible Value Trap.

Key valuation signals for INBS:

  • Short-Term Debt: $0.00 Mil
  • GF Value™: $2.64 vs. price of $1.81 (31.4% below fair value)
  • GF Score™: 50/100 with 3 warning signs

No single metric tells the full story. See the INBS stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Intelligent Bio Solutions Business Description

Address 135 West, 41ST Street, 5th Floor, New York, NY, USA, 10036
Intelligent Bio Solutions Inc is a life sciences company developing non-invasive, real-time monitoring and diagnostic tests for patients and their primary health practitioners. Its Biosensor Platform is developing and launching diagnostic tests urgently needed to help people living with chronic diseases. It also engages in the advancement of portable drug abuse testing through the analysis of fingerprint sweat. The test is non-invasive, hygienic, and fast, and screens for recent use of opioids, cocaine, methamphetamines, benzodiazepines, and marijuana. The company operates through new reportable segments: United Kingdom; Asia Pacific (APAC); Americas; and Rest of World, of which United Kingdom derives maximum revenue.
50GF Score

Get the complete analysis for INBS

Short-Term Debt is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$1.81
Price
$2.64
GF Value